文献速递妇产影像US

O-RADS、CA125与超微血管成像鉴别附件肿块良恶性的回顾性研究

Diagnostic Value of O-RADS, CA125, and Ultra Microangiography in Differentiating Benign and Malignant Adnexal Masses: A Retrospective Analysis.
PubMed 文献 · J Ultrasound Med · 2026-07-17

本研究回顾性分析320例经手术病理证实的附件肿块患者,均接受二维超声、超微血管成像(UMA)、O-RADS 2022分类及术前CA125等肿瘤标志物检测。

要点

  • O-RADS 22分类2~5类恶性检出率分别为0.00%、6.88%、42.37%、77.78%。
  • 联合诊断模型AUC达0.906(95%CI 0.869-0.942),优于任一单参数。
  • 成熟囊性畸胎瘤或子宫内膜样囊肿伴CA19-9和/或HE4阳性时联合应用价值更大。

核心结论

  • 联合O-RADS、CA125与超微血管成像可显著提高附件肿块良恶性鉴别的诊断准确性。

研究设计与样本

  • 回顾性分析320例经手术病理证实的附件肿块患者。
  • 所有患者均接受二维超声(经阴道、经腹或联合)、超微血管成像(UMA)、O-RADS 22分类(2~5类)、SUMA血流像素比测量及术前CA125、CA19-9、HE4检测。
  • 参考标准为手术病理结果。

诊断标准与关键数值

  • 在手术病理证实的320例附件肿块中,O-RADS 22分类2、3、4、5类的恶性检出率分别为0.00%、6.88%、42.37%、77.78%。
  • 单参数AUC:O-RADS 22分类0.724,SUMA血流像素比0.794,CA125 0.826,年龄0.770。

临床应用与阅片要点

  • 联合O-RADS、CA125与UMA可提高附件肿块术前良恶性风险分层能力。
  • 当成熟囊性畸胎瘤或子宫内膜样囊肿患者出现CA19-9和/或HE4阳性时,联合应用尤其有助于减少误判。
  • 日常阅片时可结合O-RADS 22分类、SUMA血流像素比与CA125进行综合判断。

局限性

  • 本研究为回顾性分析,可能存在选择偏倚。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study aimed to evaluate the diagnostic performance of the Ovarian Adnexal Reporting and Data System (O-RADS, version 2022), the tumor marker carbohydrate antigen 125 (CA125), and ultra microangiography (UMA) in distinguishing benign from malignant adnexal masses.

METHODS: A retrospective analysis of 320 patients with surgically confirmed adnexal masses was conducted. All patients underwent 2-dimensional ultrasound (transvaginal, transabdominal, or combined), UMA examination, O-RADS 22 classification (Categories 2-5), SUMA flow pixel ratio measurement, and preoperative tumor marker testing (CA125, CA19-9, HE4). Univariate and multivariate logistic regression analyses were performed. Receiver operating characteristic (ROC) curves and area under the curve (AUC) values were calculated for statistically significant variables.

RESULTS: Two hundred and forty-nine (77.8%) were benign and 71 (22.2%) non-benign. Malignancy detection rates for O-RADS 22 categories 2-5 were 0.00, 6.88, 42.37, and 77.78%, respectively. Mature teratoma (22.2%) and serous cystadenoma (16.9%) were the most common benign lesions; high-grade serous adenocarcinoma (10.9%) and borderline serous tumor (5.3%) were the most common malignant lesions. Univariate analysis showed O-RADS 22 classification, SUMA flow pixel ratio, CA125, HE4, menopausal status, age, menopausal duration, and lymphocyte count were significantly associated with diagnosis (p < .05). Multivariate analysis identified O-RADS 22 classification, SUMA flow pixel ratio, CA125, and age as independent risk factors (p < .05). AUC values were 0.724, 0.794, 0.826, and 0.770, respectively; combined AUC was 0.906 (95% CI: 0.869-0.942), significantly superior to single parameters (p < .05, DeLong test). Combined application is particularly valuable when CA19-9 and/or HE4 are positive in mature teratomas or endometriotic cysts.

CONCLUSION: Combined O-RADS, CA125, and UMA significantly enhance diagnostic accuracy for adnexal masses compared to individual modalities.

来源:J Ultrasound Med,查看原文。版权归原作者所有。

引用

  1. Liu, Kong, Su, et al. Diagnostic Value of O-RADS, CA125, and Ultra Microangiography in Differentiating Benign and Malignant Adnexal Masses: A Retrospective Analysis. J Ultrasound Med. 2026. PMID: 42464956. doi:10.1002/jum.70369

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。